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Abstract
Streptococcus agalactiae is the primary colonizer of the anogenital mucosa of up to 30% of healthy women and can infect
newborns during delivery and cause severe sepsis and meningitis. Persistent colonization usually involves the formation of
biofilm and increasing evidences indicate that in pathogenic streptococci biofilm formation is mediated by pili. Recently, we
have characterized pili distribution and conservation in 289 GBS clinical isolates and we have shown that GBS has three pilus
types, 1, 2a and 2b encoded by three corresponding pilus islands, and that each strain carries one or two islands. Here we
have investigated the capacity of these strains to form biofilms. We have found that most of the biofilm-formers carry pilus
2a, and using insertion and deletion mutants we have confirmed that pilus type 2a, but not pilus types 1 and 2b, confers
biofilm-forming phenotype. We also show that deletion of the major ancillary protein of type 2a did not impair biofilm
formation while the inactivation of the other ancillary protein and of the backbone protein completely abolished this
phenotype. Furthermore, antibodies raised against pilus components inhibited bacterial adherence to solid surfaces,
offering new strategies to prevent GBS infection by targeting bacteria during their initial attachment to host epithelial cells.
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Introduction
A number of studies have revealed that many bacteria and fungi
exist predominantly as surface-attached multicellular communi-
ties, commonly referred to as biofilms, embedded in bacterial-
derived extracellular matrix typically containing exopolysacchar-
ides, proteins and nucleic acids. Biofilm development is a multistep
process, in which component cells acquire phenotypes that are
distinct from their planktonic (or free-floating) counterparts, and is
considered critical for numerous bacterial infections [1]. To switch
from the planktonic to sessile lifestyle bacteria have to undergo a
series of genetically regulated events and several studies have
indicated that biofilm formation proceeds through a five-stage
developmental program. A loose or transient association with a
surface, followed by robust adhesion, generally identifies stages
one and two. Stages three and four involve the aggregation of cells
into microcolonies and subsequent growth and maturation. Stage
five is characterized by a return to transient motility, where biofilm
cells are sloughed off or shed [2]. The study of bacteria residing in
biofilms as an interactive community rather than free-living
planktonic cells has recently gained much attention as a result of a
recent estimate by the Centers for Disease Control and Prevention
that more than 65% of human bacterial infections involve biofilms
[3]. Many species of streptococci are known to form biofilms [4].
The complex pathway leading to biofilm development in
different species of microorganisms involves the contribution of
both environmental conditions and genetic factors. Numerous
genes or factors have been identified as being essential or required
for biofilm formation [5]. Such genes include those that regulate
surface-exposed proteins, appendages such as pili or fimbriae, and
extracellular polymeric substance (EPS) matrix materials. Pili seem
to play a key role in adhesion and attachment to host cells both in
Gram-negative and Gram-positive pathogens. Their involvement
in the transition from planktonic growth to a surface-attached
multicellular community has also been demonstrated in many
studies [6]. For instance, fimbriae and pili have been implicated in
mediating coaggregation and biofilm formation in Actinomycetes,
Enterococci and Streptococci [7,8,9,10,11].
Streptococcus agalactiae (Group B Streptococcus [GBS]) is a Gram-
positive pathogen that causes severe invasive neonatal infections,
such as pneumonia, septicemia and meningitis [12]. This microor-
ganism is also responsible for significant morbidity in pregnant
women and the elderly, and is a serious cause of mortality in
immunocompromised adults [13]. However, S. agalactiae is primarily
a commensal opportunistic organism, colonizing the gastrointestinal
and genitourinary tracts of up to 30% of healthy adults. This
asymptomatic colonization is known to precede the majority of cases
of neonatal invasive infection, acquired during delivery by direct
mother-to-baby transmission of the pathogen [14]. GBS can also
colonize the mammary glands of ruminants, where it is able to
survive for long periods, causing clinical and sub-clinical mastitis
[15,16,17]. GBS strains have been isolated, in association with other
known biofilm-forming bacteria, from biofilms on intrauterine
devices [4,18] and the ability to form biofilm in microtiter plates has
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clinical isolates from North India [19].
Three different types of pili have been characterized in GBS as
potential virulence factors and promising vaccine candidates due
to their ability to induce protective immunity in animal models
[20,21,22,23]. Such structures have also been implicated in
mediating attachment to human epithelial cells [9,24,25], in the
adhesion and invasion of brain microvascular endothelial cells [26]
and in promoting transepithelial migration [27]. The genes
involved in the synthesis and assembly of the three GBS pili are
clustered in characteristic genomic loci (named PI-1, PI-2a and PI-
2b), each encoding three structural proteins containing a LPXTG
motif and two dedicated subfamily C sortases (SrtC) involved in
covalent polymerization of the subunits [22].
In the present study, we provide evidence that GBS human
isolates can form biofilms on abiotic and biotic surfaces and that
type 2a pili are involved in biofilm formation. By analyzing a wide
panel of GBS clinical isolates, previously screened for the presence
of pili [23], we observed a statistically significant correlation
between expression of pilus type 2a and the ability to form biofilm
in vitro. The specific involvement of pilus type 2a, but not pilus
types 1 and 2b in biofilm development is here confirmed by gene
deletion and complementation analysis. Moreover, we present
data showing that the minor ancillary protein of pilus 2a, whose
role in pilus anchoring to the cell wall, a process mediated by the
constitutive sortase A has been recently demonstrated [28], plays a
key role in biofilm development. Finally, we also show that
antibodies directed against surface-exposed pilus 2a proteins are
effective in interfering with the initial steps of biofilm formation,
suggesting a potential novel strategy to inhibit bacterial adhesion
and to prevent implant-associated infections.
Results
Group B Streptococcus Strain 515 Can Adhere to
Polystyrene Plates in the Presence of Glucose and
Sucrose
To assess the capacity of GBS to form biofilms, we first analyzed
whether the serotype Ia strain 515 [29], expressing only pilus type
2a and previously used for pili genetic studies [22], was able to
adhere to polystyrene surfaces, using the well-established biofilm
assay described by O’Toole and Kolter [30]. Bacteria were grown
in tissue culture plates and biofilm formation was detected by
crystal violet (CV) staining, followed by dye solubilization with
acetic acid. Since growth medium composition influences the
capacity to form biofilm in other streptococci [31,32], GBS strain
515 was cultured under static conditions in THB, a standard
streptococcal growth medium, and in THB supplemented with
increasing concentrations of glucose and biofilm formation was
assessed after 18 hours of growth. While the presence or absence
of glucose did not affect growth rates when bacteria were cultured
in suspension (data not shown), only in the presence of glucose
concentrations $0.4%, surface adhesion and proliferation was
observed (Figure 1). Similar results were obtained using sucrose
instead of glucose (data not shown).
High Surface Exposure of Pilus Type 2a Strongly
Correlates with Biofilm Formation
To investigate if the capacity to adhere to polystyrene plates
observed in strain 515 was a general property of all GBS strains, we
next analyzed the biofilm-forming capacity of a wide panel of GBS
clinical isolates (a total of 289 strains), obtained from infants and
adults with invasive diseases. These strains had been previously
shown to express at least one of the three pilus types identified in
GBS [23]. For the screening of the entire panel of isolates, bacteria
were grown in 96 well microtiter plates in THB supplemented with
1% glucose and biofilm formation was assayed after 18 hours of
static growth. A summary of the results is given in Figure 2 where
bacteria are grouped on the basis of the expression level of pilus type
2a, as judged by FACS analysis using anti-pilus 2a antibodies [23]
(group 1: high expression, group 2: low expression, group 3:
expression not detectable). As shown in Figure 2A, 74% of the
strains expressing pilus 2a at high levels were capable of forming
biofilm, whereas low and no expression of pilus 2a resulted in a low
capacity of growing in biofilm (24% and 32.5% of the strains,
respectively). A non parametric multi-comparison analysis, using the
Behrens-Fisher test, confirmed that the group of strains expressing
high levels of pilus 2a (Group 1) was well distinguishable from the
two groups of strains in which pilus 2a was either poorly expressed
(Group 2) or not expressed (Group 3) (Figure 2B).
Scanning electron microscopy (SEM) analysis of three different
strains, GBS strain 515 and two randomly selected strains from the
pool of high biofilm formers (circled in Figure 2A) confirmed that
these strains grew on the surface in three-dimensional, multilay-
ered cell aggregates. At higher magnification the presence of cell
aggregates was apparent (Figure 3A–F). By contrast, microscopy
analysis of the surface of the well where a poor biofilm-forming
strain was grown (circled in Figure 2A) revealed the presence of
few bacteria aggregated into small monolayer islands (Figure 3G
and 3H).
In conclusion, the data so far presented indicate that a large
proportion of GBS isolates can grow in biofilm under the
experimental conditions used in this study, and that the capacity
to form biofilms seems to be associated to the presence of type 2a
pili on the bacterial surface.
Pilus Variant 2a Is Specifically Required for Biofilm
Formation In Vitro
The data shown above suggest that only pilus type 2a and not
the other pilus types plays a role in biofilm formation. To support
Figure 1. Influence of glucose on biofilm formation in GBS
strain 515. Determination of biofilm formation by crystal violet (CV)
assay of GBS strain 515 grown in THB supplemented with different
glucose concentrations in 96-well polystyrene plates under static
conditions at 37uC, 5% CO2 for 18 hours. Crystal violet stained, surface-
attached cells were quantified by solubilizing the dye in 30% acetic acid
and by measuring the absorbance at 540 nm. The mean values of three
independent experiments and standard deviation are shown.
doi:10.1371/journal.pone.0009216.g001
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strain 515DPI-2a in which the whole pilus island 2a was deleted
and we complemented this non piliated strain with each of the
three pilus islands identified in GBS. Complementation was
carried out by transforming the mutant 515DPI-2a with recom-
binant pAM401 plasmids carrying the whole pilus islands. Western
Blotting and FACS analyses using antibodies specific for each pilus
type confirmed the absence of pili in 515DPI-2a and the expression
of the corresponding pilus type in the complemented strains
515DPI-2a/pAM-PI-1, 515DPI-2a/pAM-PI-2a and 515DPI-2a/
pAM-PI-2b (Figure 4A and 4B). The deletion mutant strain
515DPI-2a and its complemented strains expressing a single pilus
type were then analyzed for their capacity to form biofilms on
abiotic surfaces. As shown in Figure 4C, deletion of the whole pilus
island 2a abolished the ability of bacteria to adhere to the plates
and only the complemented strain expressing pilus 2a, and not
those expressing pilus 1 and 2b, was able to significantly adhere to
plates. Similar data were obtained when plates were coated with a
purified Extracellular Matrix derived from human placenta,
enriched of laminin, collagen type IV and heparan sulfate
proteoglycan (Figure 4C). To further confirm the specific
involvement of only pilus 2a in biofilm formation we investigated
the ability to adhere to polystyrene plates of biofilm-forming strains
expressing the other two pilus types (pilus 1 or pilus 2b), in which
we knocked out the corresponding backbone protein essential for
pilus polymerization (Figure 5A). These deletion mutant strains
were not able to express pili on their surface (data not shown), yet
the lack of pilus expression did not impact their ability to form
biofilms on polystyrene plates (Figure 5B).
Role of Pilus 2a Subunits and Sortase A in Biofilm
Formation
To investigate the role of each gene of pilus island 2a (Figure 6A)
in biofilm formation, we also analyzed biofilm formation in the
mutant strains, generated in strain 515, lacking either one of the
three structural LPXTG proteins (BP, AP1 and AP2) or the two
SrtC-like sortases SrtC-1 and SrtC-2 [22]. As published elsewhere,
inactivation of either the backbone protein BP or both sortases
results in the loss of pilus whereas pilus assembly still occurs in
mutants lacking the two ancillary proteins (AP1 and AP2) and one
of the two sortases [22]. Consistently with these data, biofilm
formation in mutants lacking pili was abolished (Figure 6B). By
contrast, deletion of the AP1 gene (DAP1), or deletion of the sortase
SrtC-2 (DsrtC-2) involved in the incorporation of AP1 protein into
the pilus structure, did not affect biofilm formation. Finally, the
mutant lacking the AP2 gene (DAP2-2a), as well as inactivation of
Figure 2. Correlation between surface exposure of pilus type 2a and biofilm formation. (A) Determination by crystal violet (CV) assay of
biofilm formation of 289 GBS clinical isolates grown in 96-well polystyrene plates in THB supplemented with 1% glucose at 37uC for 18 h. Adherent
bacteria were stained with crystal violet (CV) and quantified by measuring the absorbance at 540 nm. The data represent the mean values of three
experiments. Standard deviations (not shown) ranged from OD540 values of 0.02 to 0.1. Strains were distributed into 3 groups according to the level
of expression of pilus type 2a (PI-2a, Pilus Island 2a), measured by flow cytometry as the Fluorescence Fold Increase (FFI) of cells stained with anti-
pilus 2a sera over cells stained with pre-immune sera. Group 1 (High pilus expression: PI-2a .5 FFI) including 171 strains; Group 2 (intermediate or
low pilus expression: PI-2a ,5 FFI) including 38 strains and Group 3, in which the PI-2a was absent, including 80 strains. Group 1 or Group 2 were
also subdivided in strains expressing high levels of pilus type 1 (PI-1.5) and strains carrying only pilus 2a (PI-1 absent) or expressing pilus type 1
below the threshold level (PI-1,5). Group 3 was subdivided into strains expressing either PI-1 or PI-2b at high levels (FFI .5) and strains in which
also PI-1 and PI-2b poorly expressed (FFI ,5). The horizontal bar intersecting the value of absorbance 0.65 represents the cut-off established to
discriminate between high-biofilm forming strains and low-biofilm forming strains. The cut-off was calculated as the value equidistant from the
median of absorbance of groups 1, 2 and 3. The percentages are calculated considering the number of strains over or below the cut-off value.
Circles indicates strains used for SEM analysis shown in Figure 3. (B) Non parametric multi-comparison statistical analysis. The Kruskal-Wallis test
was applied to test the equality of population median among the groups and confirmed that the three groups did not belong to the same
population (p-value=1.742 e
208). The Behrens-Fisher test was applied to distinguish which of the groups were significantly different. Each of the
lines connecting two groups is proportional to their comparison p-value and confirms a strong relation between Gr.2 and Gr.3, while the Gr.1 was
found to be very different from the others.
doi:10.1371/journal.pone.0009216.g002
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pilus, reduced the ability of GBS to form biofilms (Figure 6B).
Complementation of all biofilm-defective mutant strains restored
biofilm formation to a level comparable with that of the wild-type
strain (Figure 6C). Identical results were obtained both on abiotic
and biotic surfaces (data not shown). The fact that mutant strains
impaired in AP2 synthesis (DAP2) or AP2 covalent binding to the
backbone protein BP (DsrtC-1) are unable to form biofilms is
consistent with the role of the minor ancillary as pilus anchoring
protein [28]. In terms of biofilm formation these mutants, which
tend to release polymerized pili into the culture supernatants,
behave like a non piliated strain. Also in line with this is the
phenotype of DsrtA mutant. The constitutive SrtA catalyzes the
covalent binding of the minor ancillary AP2 to peptidoglycan and
since its inactivation leads to pilus secretion [28], the 515 DsrtA
mutant is incapable of forming biofilms according to data obtained
in GBS NEM316 DsrtA mutant strain (Figure 6B and [9]). The
wild type phenotype was completely restored when the 515 DsrtA
mutant strain was complemented with a plasmid expressing the
complete srtA gene (DsrtA+) (Figure 6C).
To further confirm the phenotypes observed in the CV assay,
the entire panel of PI-2a deletion mutants was analyzed by
confocal laser scanning microscopy (CLSM). Bacteria were
incubated in chambers containing glass polylysine-coated cover-
slips and after 72 h the wells were emptied and washed. Adherent
bacteria were stained with Syto-9 and examined by CLSM.
Images were analyzed for morphology and biofilm thickness. As
shown in Figure 7A, the wild type strain 515 formed structured
multilayered aggregates of surface-adherent bacteria resembling a
mature biofilm, with an average thickness of 12.561.2 mm.
Similar structures were also seen with deletion mutants for AP1
and AP1-specific sortase SrtC-2, with an average thickness of
13.761.2 and 12.361.2 mm, respectively (Figure 7B and 7E). On
the contrary, deletion mutants for the minor ancillary protein AP2
and the AP2-specific sortase SrtC-1 were biofilm-defective
(Figure 7G and 7D). In addition, the double sortases mutant
(Figure 7F), the deletion mutant for the backbone protein BP
(Figure 7C), and the mutant lacking the entire pilus island
(Figure 7H) were also ineffective in biofilm formation. Overall, all
biofilm-defective strains formed a low-profile biofilm, averaging
2.3 mm in height.
Taken together, these data indicated that the presence of a
polymerized pilus, correctly anchored to the cell wall, a process
that involves both ancillary protein AP2, sortase SrtC-1 and
Sortase A, is necessary for efficient biofilm formation. By contrast,
loss of the major ancillary protein AP1 or of the sortase SrtC-2
responsible for AP1 incorporation in the pilus does not affect the
ability of bacteria to adhere to surfaces.
Antibodies against Surface-Exposed Pilus 2a Proteins
Inhibit Biofilm Formation
In order to obtain further insight into the role of pilus variant 2a
in biofilm development, we investigated whether polyclonal
antibodies against each of the three structural pilus proteins (BP,
AP1 and AP2) inhibited the ability of GBS wild type strain 515 to
form biofilms. Bacteria were grown under static conditions in the
presence of increasing concentrations of purified polyclonal
antibodies and biofilm was quantified after 18 hours. As reported
in Figure 8, the presence of anti-BP antibodies significantly
inhibited biofilm formation in a dose-dependent manner.
Inhibition was also observed in the presence of anti-AP1
antibodies despite the fact that our deletion analysis showed that
this ancillary protein is dispensable for biofilm formation. This
result suggests that antibody binding to AP1, which is intimately
associated to the backbone protein BP, is sufficient to interfere
with the cell-to-cell contact promoted by pilus 2a. Finally,
antibodies against AP2 had no effect on biofilm formation, in
agreement with the location of this ancillary protein which, being
embedded in the cell wall, is not accessible to antibodies [22,28].
Biofilm inhibitory activity was pilus–specific since biofilm
formation was unaffected in the presence of antibodies specific
for the highly surface exposed protein Sip (TIGR annotation
SAG_0032) [33]. Interestingly, antibodies specific for the back-
bone protein of pilus type 1 and 2b did not inhibit the capacity to
adhere to plates of high-biofilm forming strains expressing on their
surface at very high levels or pilus 1 or pilus 2b (data not shown).
These data represent a further evidence that only pilus 2a, but not
the other two pili, is involved in biofilm formation in vitro.
Figure 3. Morphological analysis of GBS biofilms by Scanning
Electron Microscopy. Representative SEM images of three different
GBS high-biofilm former strains (A–F) and of a low-biofilm former strain
(G–H). Bacteria were grown on uncoated glass coverslips for 72 h in
static conditions. (A and B) Strain CHR-021, serotype Ia with
magnification 6500 (A) and 6100 (B). (C and D) Strain ABC020018145,
serotype II with magnification62000 (C) and65000 (D). (E and F) Strain
515, serotype Ia with magnification 61500 (E) and 65000 (F). (G and H)
Strain CHR-019, serotype III with magnification 61500 (G) and 65000
(H).
doi:10.1371/journal.pone.0009216.g003
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In pathogenic bacteria persistent colonization usually involves
biofilm formation and pili have been shown to be part of the
components which promote bacterial aggregation and attachment
to the host surfaces. Since asymptomatic colonization of maternal
vaginal mucosa by GBS is the major risk factor for sepsis and
meningitis in newborns, and since GBS is decorated with pili, it
was of interest to investigate the possible role of pili in GBS
colonization and biofilm formation. We have previously shown
that three pilus types (type 1, type 2a and type 2b), encoded by
three distinct genetic islands, are present in GBS, and all isolates so
far characterized carry one or a combination of two islands. Pilus
type 2a, which includes seven variants based on the amino acid
sequences of its structural proteins, appears to be the most
represented of the pilus types, being present in over 70% of the
clinical isolates analyzed and, in contrast with the other two pilus
types, was found alone in a large number of strains (27%) [23].
Therefore, we first analyzed the ability of a type 2a-carrying strain
(GBS 515) to form biofilms on both plastic and biotic surfaces and
we demonstrated that the strain was in fact capable of growing as a
surface-attached multicellular community resembling a biofilm-
like structure. This is in line with data recently published by
Konto-Ghiorghi and coauthors, who reported that GBS strain
Figure 4. Role of the three pilus islands in biofilm formation. (A) Western Blot analysis of total protein extracts from GBS strain JM9130013
expressing both PI-1 and PI-2b, strain 515 expressing only PI-2a, the deletion strain 515DPI-2a (no pilus expression) and the strain 515DPI-2a,
complemented with each of the three pilus islands: pilus island 1 (DPI-2a/pAM-PI-1), pilus island 2a (DPI-2a/pAM-PI-2a) and pilus island 2b (DPI-2a/
pAM-PI-2b). The membranes were probed with antisera specific for the backbone proteins of pilus 1 (a -BP-1), pilus 2a (a -BP-2a) and pilus 2b (a -BP-
2b). High molecular weight polymers, which indicate incorporation of the protein into pilus-like structures were detected. (B) Flow cytometry analysis
of 515DPI-2a (no pilus expression), complemented with an empty pAM plasmid and with each of the three pilus islands, 515DPI-2a/pAM-PI-1, 515DPI-
2a/pAM-PI-2a and 515DPI-2a/pAM-PI-2b, probed with antisera specific for pilus 1 (a -BP-1), for pilus 2a (a -BP-2a) and for pilus 2b (a -BP-2b). (C)
Quantification of biofilm formation by crystal violet assay of GBS wild type strain 515 (515 WT), GBS 515DPI-2a and the complemented strains 515
DPI-2a/pAM-PI-1, DPI-2a/pAM-PI-2a and DPI-2a/pAM-PI-2b. Bacteria were grown under static conditions at 37uC for 18 h in 96-well uncoated
polystyrene plates and on plates coated with a purified Extracellular Matrix (ECM) derived from human placenta. Crystal violet-stained, surface-
attached cells were quantified by solubilizing the dye in 30% acetic acid and determining the absorbance at 540 nm. The mean values of three
independent experiments and standard deviation are shown.
doi:10.1371/journal.pone.0009216.g004
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variant, was able to form biofilms in microtiter plates [9]. Next, we
characterized the biofilm-forming phenotype of a large panel of
clinical isolates and we found that the majority of the biofilm
formers carried type 2a pili. This observation led us to
demonstrate by gene deletion/complementation analyses, that
only type 2a pili, and not type 1 and type 2b, participate to biofilm
formation in GBS. This is of particular interest since it is the first
indication that the three pilus types in GBS fulfill different
functions and that a particular pilus pattern is associated with
specific functional features that could be relevant for pathogenesis.
However, it remains to be clarified the biological significance of
this difference. In fact, from our previous extensive analysis of pili
distribution in 289 clinical isolates no significant correlation
between pilus type and the nature/severity of disease emerged
[23]. This apparent discrepancy, which deserves additional
studies, could be explained considering that our pilus expression
Figure 5. Role of pilus type 1 and pilus type 2b in biofilm
formation. (A) Schematic representation of Pilus Island 1 (PI-1) and
Pilus Island 2b (PI-2b). Genes encoding the three LPXTG proteins are
represented by black (BP-1, backbone protein of pilus 1; BP-2b,
backbone protein of pilus 2b) and white (AP1-1 and AP2-1, ancillary
protein 1 and ancillary protein 2 of pilus 1; AP1-2b and AP2-2b, ancillary
protein 1 and ancillary protein 2 of pilus 2b) arrows. SrtC transpeptidase
genes (SrtC1 and SrtC-2) are shown in gray. (B) Quantification of biofilm
formation by crystal violet assay of GBS wild type strain CJB111
expressing pilus type 1 (WT, PI-1) and GBS wild type strain
ABC020017623 expressing pilus type 2b (WT, PI-2b) in comparison
with the corresponding deletion mutant strains lacking the pilus
expression. DBP-1, strain CJB111 with in-frame deletion of the gene
coding for the backbone protein of pilus 1; DBP-2b,s t r a i n
ABC020017623 with in-frame deletion of the gene coding for the
backbone protein of pilus 2b. Bacteria were grown under static
conditions at 37uC for 18 h in 96-well uncoated polystyrene plates and
surface-attached, crystal violet-stained cells were quantified by
solubilizing the dye in 30% acetic acid and determining the absorbance
at 540 nm. The mean values of three independent experiments and
standard deviation are shown.
doi:10.1371/journal.pone.0009216.g005
Figure 6. Contribution of pilus 2a subunits and sortase A in
biofilm formation. (A) Schematic representation of pilus island 2a in
GBS strain 515. Genes encoding the three LPXTG proteins are
represented by black (backbone protein, BP-2a) and white (ancillary
proteins 1 and 2, AP1-2a and AP2-2a) arrows. SrtC transpeptidase genes
(SrtC1 and SrtC-2) are shown in gray. (B) Comparison of biofilm
formation by crystal violet assay between GBS wild type strain 515
(515 WT), and the deletion mutant strains 515 for the whole pilus island
2a (515DPI-2a), for AP1 gene (DAP1-2a), for BP gene (DBP-2a), for SrtC1
gene (DsrtC1), for SrtC-2 gene (DsrtC-2), for both sortases genes (DsrtC-
1/2), for AP2 gene (DAP2-2a) and for Sortase A gene (DsrtA). Cells were
grown in polystyrene plates at 37uC for 18 hours. Adherent bacteria
were stained with crystal violet and quantified by measuring the
absorbance at 540 nm. (C) Comparison of biofilm formation by crystal
violet assay between the 515 deletion mutant strains (DAP1-2a, DBP-2a,
DAP2-2a, DsrtA), complemented with an empty pAM401 expression
vector alone and the corresponding complemented strains: DAP1-2a+,
strain 515 DAP1-2a complemented by a plasmid containing the
complete AP1-2a coding sequence; DBP-2a+,s t r a i n5 1 5DBP-2a
complemented by a plasmid containing the BP-2a gene; DAP2-2a+,
strain 515 DAP2-2a complemented by a plasmid containing the AP2-2a
gene; DsrtA+, strain 515 DsrtA complemented by a plasmid containing
the complete srtA coding sequence. Bacteria were grown under static
conditions in polystyrene plates at 37uC for 48 h. Crystal violet-stained,
surface-attached cells were quantified by solubilizing the dye in 30%
acid acetic and determining the absorbance at 540 nm. The mean
values of three independent experiments and standard deviations are
shown.
doi:10.1371/journal.pone.0009216.g006
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conditions which do not necessarily reflect the real situation during
natural colonization/infection. Alternatively, or in addition, it
becomes apparent that each pathogenic bacterial species is armed
with a battery of different components/virulent factors which can
be expressed in different combinations to escape the innate and
adaptive immune responses of the host. In GBS, pili appear to be
part of these virulent factors and the absence of type 2a pili in one
isolate could be compensated by the expression of another, still to
be identified, component that exerts similar functions (i.e. adhesion
properties). Biofilm formation is a typical example of how bacteria
utilize different components to reach the same goal, namely,
colonizing the host mucosal surfaces. The multi-factorial process of
cell-to-cell contact and adhesion has been demonstrated in a
Figure 7. Confocal Laser Scanning Microscopy of biofilm formation by PI-2a deletion mutants. CLSM micrographs comparing biofilm
formation of the wild type GBS strain 515 and the deletion mutant strains for each pilus 2a gene. (A) 515 WT, wild type strain 515; (B) DAP1-2a, strain
515 DAP1-2a with in-frame deletion of the AP1-2a gene; (C) DBP-2a, strain 515 DBP-2a with in-frame deletion of the BP-2a gene; (D) DsrtC-1, strain 515
DsrtC-1 with in-frame deletion of the sortase srtC-1 gene; (E) DsrtC-2, strain 515 DsrtC-2 with in-frame deletion of the sortase srtC-2 gene; (F) DsrtC-1/2,
strain 515 DsrtC-1/2 with in-frame deletion of both sortase genes; (G) DAP2-2a, strain 515 DAP2-2a with in-frame deletion of the AP2-2a gene; (H)
515DPI-2a, strain carrying deletion of the whole pilus island 2a. Bacteria were grown under static conditions at 37uC for 72 hours on glass coverslips.
Then, biofilms were fixed and stained immediately prior to analysis with SYTO-9 (magnification 606). Biofilm thickness was measured in different
points of each field, and the means and standard deviations of at least three measurements are shown.
doi:10.1371/journal.pone.0009216.g007
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and, as shown in this work, it appears to be the case for GBS as
well. Indeed, we observed that a quite consistent number of strains
not expressing pilus 2a were able to form biofilms. Therefore, in
these strains other still unknown factor(s) should be expressed to
compensate for the absence of pili.
When we analyzed the role of each gene located in pilus island
2a in biofilm formation by gene deletion/complementation
analysis, we found that any mutation that either abrogates pilus
expression (deletion of the backbone protein, or concomitant
deletion of sortase-encoding genes) or impairs pilus anchoring to
the cell wall (deletions of AP2, srtC-1, srtA genes) prevents biofilm
formation. On the contrary, inactivation of the major ancillary
protein AP1, which decorates the shaft of type 2a pili [22], as well
as the loss of the AP1-specific sortase-C (SrtC-2), does not affect
the capacity of GBS strain 515 to adhere and aggregate on plastic.
These data suggest that a polymerized pilus, correctly anchored to
the cell wall, is essential for biofilm formation whereas the
abrogation of AP1 expression does not impact both pilus
polymerization and biofilm formation. Biofilm inhibition observed
in the presence of antibodies specific for AP1, in contrast with the
data for the AP1 mutant in biofilm development, may be
explained as a steric hindrance resulting from antibody binding
to AP1, which is intimately associated with the backbone protein
BP. Conversely, the lack of inhibition of antibodies against the
minor ancillary protein AP2 was expected, being this protein not
surface-exposed, so not accessible to antibodies, as shown from
previous works [22,28]. However, the biofilm-defective phenotype
shown by the mutant strain for the minor ancillary AP2 is
consistent with the well demonstrated role of this protein as the
anchor protein utilized by sortase A in covalent anchoring of pilus
2a to the cell wall [28]. According to this, also the sortase A
mutant strain showed a defective phenotype as well as the KO
strain lacking the sortase C specific for AP2 incorporation into
pilus. Nevertheless our findings are partially in contrast with those
reported for GBS strain NEM316 by Konto-Ghiorghi and
coauthors. In this study the authors observed that deletion of the
entire PilA gene (homologous of AP1 in GBS 515) caused loss of
biofilm formation, while the deletion of PilC gene (homologous of
AP2 in GBS 515) did not affect biofilm formation [9]. At present,
the reason for this discrepancy is not clear. One possible
explanation is that GBS 515 and GBS NEM316 carry type 2a
pili belonging to different variants [23] whose structural
components might differ in their role in cell aggregation and
surface adhesion. In particular it would be interesting to
investigate the role of PilC, which according to the data reported
by Konto-Ghiorghi and coauthors, should not have the pilus
anchoring role of its homologous AP2-2a [9,28] and, differently
from AP2-2a, should be exposed on the bacterial surface.
All three pili identified in GBS elicit protective immunity and
vaccines based on a combination of pili components provide broad
protection in the mouse model [23]. It is noteworthy that
antibodies raised against both the backbone protein and the
major ancillary protein of pilus island 2a block the formation of
biofilms on both abiotic and biotic surfaces. These observations
suggest that a pilus-based vaccine may work according to two
different mechanisms of action, namely, the elicitation of
opsonophagocytic antibodies capable of killing bacteria in a
complement-dependent manner and the induction of antibodies
capable of preventing colonization in the host. This observation
could be of relevance for other piliated Gram-positive pathogens,
including S. pyogenes and S. pneumoniae, known to grow in biofilm on
biological surfaces and implanted medical devices such as
catheters and artificial prosthetics [37].
Materials and Methods
Bacterial Strains, Plasmids, Media and Growth Conditions
GBS isolates analyzed in this work were collected by the Center
for Disease Control and Prevention (CDC), Atlanta (100 strains);
Baylor College of Medicine (BCM), Houston (103 strains) and
Istituto Superiore di Sanita `, Italy (86 strains). The classification of
the strains on the basis of disease and serotype has been previously
reported [23]. Strains CJB111 (type V), JM9130013 (type VIII)
and 515 (type Ia) were kindly provided from Dr. Dennis Kasper
(Harvard Medical School, Boston, MA, USA) [29]. The
construction of the GBS 515 deletion mutant strains for each of
the three structural LPXTG proteins of pilus type 2a (DBP-2a,
DAP1-2a, DAP2-2a), for the two SrtC-family sortases, DsrtC-1,
DsrtC-2 and DsrtC-1/2 and for sortase A (DsrtA) have been already
described [22,28]. The in-frame deletion mutants for the entire
pilus island 2a in 515 strain (515DPI-2a), for the backbone protein
of pilus 1 in CJB111 strain (DBP-1) and for the backbone protein
of pilus 2b in strain ABC020017623 (DBP-2b) were generated
using Splicing by Overlap Extension (SOE) PCR as described
previously [22,38]. For the construction of 515DPI-2a, two DNA
fragments were obtained by PCR amplification from genomic
DNA using primers PI-2a-for/PI-2a-revA (59-GATTTTGCT-
CTCGAGGCTTACCTTGAAAAATCTGCTGATG-39/59-CC-
AAGAATTGTCAGTCCTCCACCAACCATTTTCCGGTAC-
GGTACTTTC-39) and PI-2a-forA/PI-2a-rev (59- GAAAGTA-
CCGTACCGGAAAATGGTTGGTGGAGGACTGACAATTC -
TTGG-39/59- AGCTTCTGGCTCGAGTATAGCATCCCCT-
GAACCAGAAAC-39). These fragments, overlapping for 24 bp,
were used as a template to generate a PCR fragment comprising
the flanking sequences of the PI-2a genomic locus using primers
PI-2a-for/PI-2a-rev. For the construction of the mutant DBP-1 we
used the primers BP-1-forA/BP-1-revA (59- TCAGGATCCG-
CAACAATCTGTTCTGAC-39/959- AACAGCAAAAGCCAT-
CACTTTCGCTGGGCGTTCTTGTGACAC-3) and primers
BP-1-forB/BP-1-revB (59-CAAGAACGCCCAGCGAAAGTGA-
TGGCTTTTGCTGTTAAGGGG-39/59-CGGGATCCAAAT-
Figure 8. Inhibition of biofilm formation by antibodies against
pilus 2a proteins. GBS strain 515 was grown in 96-well polystyrene
plates at 37uC for 18 hours in the presence of serial dilutions of purified
rabbit polyclonal antibodies directed against each of the pilus 2a
structural protein (anti-BP-2a, anti-AP1-2a, anti-AP2-2a) and against the
surface protein Sip (anti-Sip) used as a control. Biofilm formation was
then measured by crystal violet assay, determining the absorbance at
540 nm. The mean values of three independent experiments and
standard deviations are shown.
doi:10.1371/journal.pone.0009216.g008
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deletion mutant strain DBP-2b the primers used were: BP-2b-
forA/BP-2b-revA (59-TCAGGATCCGGTAACGGTGGTACTA-
GAGTAG-39/59- ACCTGTTGAAGGCAACTCAGTACCATC-
TTGAACTGTAATTGTCCCTGTC-39) and BP-2b-forB/BP-2b-
revB (59-GACAGGGACAATTACAGTTCAAGATGGTACTG-
AGTTGCCTTCAACAGGT-39/59-G T G T G A GTCGACGCTT-
GTGCTACTTGGTAAACAAG-39). The PCR deletion constructs
were digested with the appropriate restriction enzyme (BamHI,
XhoI or SalI) and ligated to the temperature-sensitive allelic
exchange vector pJRS233, which was a gift from June Scott [39].
Transformations and allelic exchanges were performed essentially as
described [40]. Screening for the deletion alleles was done by PCR
amplification and sequencing using primers DPI-2a-for and DPI-2a-
rev (59-AAAGGGGTGAGTAAGGGACAAC-39 and 59-AACC-
TTTGTCTTCTCCCATCC-39); primers DBP-1-for and DBP-1-
rev (59-AATGGTGGCGGGGTCAAC-39 and 59-TCTTTAGGG-
GCAATCTCCAACTG-39)a n dp r i m e r sDBP-2b-for and DBP-2b-
rev (59-CAGTAAAGGAACAGAATTGCC-39 and 59-CATAAT-
CGCTCGAGATTGGTG-39).
The construction of the complementation vectors 515 DBP-2a+,
515 DAP1-2a+, 515 DPI-2a/pAM-PI-1 and 515 DsrtA+ have been
previously described [22,28,41]. The complementation vector 515
DAP2-2a+ was constructed using the primers p150-f (59- CAC-
CTGTCATGCGGCCGCGAAAGAGAAAGGGAAATCAAAA-
39) and p150-r (59CTCTCTCTGAGATCTAACTTGCAATTG-
CAAGTT-39) to amplify from the 515 genome a 1023 bp
fragment containing the open reading frame coding for the AP2-
2a protein. The complementation vectors 515DPI-2a/pAM-PI-2a
and 515DPI-2a/pAM-PI-2b were constructed using the primers
pPI-2a-f/pPI-2a-r (59-CACCTGTCATGCGGCCGCCAATAG-
GAGTTGTAAAATGAG-39/59- CTCTCTCTGAGATCTCTA-
ATTAGTAGTAGTG-39) and primers pPI-2b-f/pPI-2b-r (59-
CACCTGTCATGCGGCCGCGGAGGATGCAAAAATGCTA -
39/59-CTCTCTCTGAGATCTGTAGTAGATTGTATAATA -
TTA -39), respectively, to amplify from the strain 515 genome a
7753 bp fragment containing the entire pilus island 2a and from
the strain COH1 genome a 8081 bp fragment comprising the
entire pilus island 2b. All complementation vectors were
electroporated into the corresponding deletion mutant strains.
For all complementation experiments, the empty pAM401
plasmid, introduced into wild-type strain 515 and deletion mutant
strains, was used as a negative control.
For PCR amplification experiments, genomic DNA was isolated
from GBS strains by mutanolysin-treatment of bacterial cells using
a NucleoSpin Tissue kit (Macherey-Nagel), according to the
manufacturer’s instructions. Plasmids and PCR products were
purified using a Wizard Plus SV Miniprep System and a Wizard
SV Gel/PCR Clean-Up System (Promega).
Bacteria were routinely grown at 37uC in Todd Hewitt Broth
(THB; Difco Laboratories) or in trypticase soy agar plates
supplemented with 5% sheep blood. For biofilm experiments
bacteria were grown in Todd Hewitt broth (THB) supplemented
with 1% glucose in 96-well polystyrene tissue culture plates.
Biofilm Formation Assay
The biofilm formation assay used in this study is based on the
ability of bacteria to adhere and form biofilms on solid surfaces as
previously reported [42]. All biofilm experiments were performed
in 96-well polystyrene flat-bottom microtiter plates (Costar),
uncoated or coated with 3 mg/well of human Extracellular Matrix
(BD, Becton Dickinson, Cat. No. 354237) overnight at 4uC. GBS
strains grown overnight in THB-1% glucose were diluted 1:20 in
fresh medium and 100 ml cultures were added to each well
previously rinsed three times with PBS. Wells filled with growth
medium were included as negative controls. Plates were incubated
without shaking at 37uC for 18 h aerobically in 5% CO2.
Complemented strains were grown without antibiotic selection
for 48 h. Before biofilm quantification, growth of wild type and
mutant strains was assessed by measuring the absorbance of
cultures in the wells at 600 nm with a spectrophotometer. Media,
including any unattached bacteria, were then decanted from the
wells, and any remaining planktonic cells were removed by rinsing
with ddH2O. Wells were air dried, and adherent bacteria were
stained for 10 min with a 0.5% (wt/vol) solution of Crystal Violet.
After rinsing with ddH2O, bound dye was released from stained
cells using 30% glacial acetic acid. This allowed indirect
measurement of biofilms formed on both the bottom and sides
of the well. Biofilm formation was quantified by measuring
absorbance of the solution at 540 nm with a microplate reader
(Tecan, Infinite M200). Each assay was performed in triplicate and
repeated three times. For the biofilm inhibition assay, rabbit
antibodies were purified using protein G sepharose, according to
the manufacturer’s instructions (Ab Spin Trap, GE Healthcare)
and tested for their ability to inhibit biofilm formation. A GBS
overnight culture was diluted 1:50 in fresh medium and inoculated
into wells of polystyrene flat-bottom 96-well microtiter plate with
serial dilutions of purified antibodies in a final volume of 250 ml.
Plates were incubated at 37uC for 18 hours aerobically in 5%
CO2. Samples with no addition of purified antibodies or with
normal rabbit serum were included as controls. Biofilm quanti-
fication was performed as already described.
Statistical analysis of biofilm formation in the panel of 289 GBS
strains was performed using R-2.9.0 software. Kruskal-Wallis and
Beherens-Fisher tests were used for the non parametric multi-
group comparisons.
Recombinant Proteins and Polyclonal Antibody
Production
Genes coding for LPXTG proteins were expressed as 6His-tagged
fusion proteins and purified by affinity chromatography as previously
reported [21,22,23,43]. Purified recombinant GBS proteins were
used for intraperitoneal immunization of CD-1 outbred mice or to
immunize New Zealand rabbits (Charles River Laboratories, Calco
Italy). As reported previously, antisera against each protein did not
show cross-reactivity with other pilin proteins [22].
Western Blotting Analysis
Mid-exponential phase cells were harvested, washed in PBS and
resuspended in 50 mM Tris-HCl, containing 400 units of
mutanolysin (Sigma). Bacterial suspensions were then incubated
at 37uC for 2 hrs and cells lysed by three consecutive cycles of
freeze-thawing. Cellular debris were removed by centrifugation at
13000 rpm for 10 minutes and protein concentration measured by
Bio-Rad Protein assay (Hercules, CA). Protein extracts (20 mg)
were separated on 3–8% NuPage Novex SDS-PAGE gels
(Invitrogen) and electroblotted onto nitrocellulose membranes.
After blocking, membranes were incubated for 1 hour at room
temperature (RT) with mouse primary antibodies diluted 1:500,
washed twice in PBS-Tween and incubated for 1 hour with a
rabbit anti-mouse horseradish peroxidase-conjugated secondary
antibodies (Dako). Bands were then visualized using an Opti-4CN
Substrate Kit (Bio-Rad).
Flow Cytometry
Exponential phase bacterial cells were harvested, washed in
PBS, resuspended in PBS containing 0.08% (wt/vol) paraformal-
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washed once with PBS, resuspended in Newborn Calf Serum
(Sigma) and incubated for 20 min. at 25uC. The cells were then
incubated for 1 hour at 4uC in pre-immune or immune sera,
diluted 1:200 in dilution buffer (PBS, 20% Newborn Calf Serum,
0.1% BSA). Cells were washed in PBS-01% BSA and incubated
for a further 1 h at 4uC with a 1:100 dilution of R-Phycoerythrin
conjugated F(ab)2 goat anti-mouse IgG (Jackson ImmunoResearch
Laboratories; Inc.),. After washing, cells were resuspended in PBS
and analyzed with a FACS Calibur apparatus (Becton Dickinson,
Franklin Lakes, NJ) using FlowJo Software (Tree Star, Ashland,
OR).
Confocal Laser Scanning Microscopy (CLSM)
For all microscopic experiments, biofilms were allowed to grow
at 37uC in 5%CO2 for 72 hours on glass sterile coverslips (BD,
Biocoat) placed in 24-well polystyrene cell culture plates (Costar).
Samples were then fixed with paraformaldehyde in 100 mM
phosphate buffer pH 7.4 for 20 min, washed with PBS and
blocked with PBS 3% (w/v) BSA, 1% (w/v) saponin (blocking
solution) for 15 min. Fixed bacteria on coverslips were stained
with SYTO-9 (488 nm excitation, green emission) or with red-
fluorescent propidium iodide nucleic acid stain 490 nm (Molecular
Probes). Coverslips were then washed with PBS and ddH2O,
mounted on glass slides with the ProLongH Gold antifade reagent
(Molecular Probes) and viewed on a BioRad Radiance 2000
Scanning Laser Confocal Microscope (CLSM). Three-dimensional
immunofluorescence images were reconstructed from 0.5-mm
confocal optical sections by using VOLOCITY 3.6 (Improvision,
Lexington, MA). The confocal optical sections from random fields
were collapsed into single projections.
Scanning Electron Microscopy (SEM)
Bacteria were let to attach to poly-L-lysinated coverslide and
then fixed in 2.5% paraformaldehyde-2.5% glutaraldehyde in
cacodylate sucrose buffer (0.1 M cacodylate, 0.1 M sucrose, 5 mM
CaCl2, 5 mM MgCl2, pH 7.2) overnight at 4uC, rinsed in
cacodylate buffer at pH 7.2 (3 changes for 30 min at 4uC) and
then post-fixed in 1% osmium tetroxide in the same buffer for one
hour at 4uC. Then they were dehydrated in an ascending series of
alcohol (30%–100%) and critical point dried in a Balzer’s
apparatus equipped with a liquid CO2 inlet and metal shadowed
in a gold sputtering unit equipped with an argon inlet. Specimens
were examined in a Jeol JSM 5200 scanning electron microscope.
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